Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azathioprine or 6-mercaptopurine versus infliximab monotherapy for maintenance of remission in Crohn's disease
NL-OMON32054Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2008
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Trial of infliximab, azathioprine and mercaptopurine, sponsored by Amsterdam University Medical Center. Planned start Jun 2008; status: not yet recruiting.
02
Drugs
infliximabazathioprinemercaptopurine
Beyond the preview
Go deeper on NL-OMON32054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32054.